SCHEMBL4871885

SCHEMBL4871885

CC(C)(C)C(=O)OCOP(=O)(OCOC(=O)C(C)(C)C)c1ccc(-c2nc(N)sc2C(=O)C2CCC2)o1

nearest known ligand 0.50

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
FBP1 P09467 20/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080070868-A1 Novel Thiazole Inhibitors of Fructose 1,6-bisphosphatase METABASIS THERAPEUTICS, INC. (US) 2008-03-20 US disclosed
US-20080070868-A1 Novel Thiazole Inhibitors of Fructose 1,6-bisphosphatase METABASIS THERAPEUTICS, INC. (US) 2008-03-20 US disclosed
US-20080070868-A1 Novel Thiazole Inhibitors of Fructose 1,6-bisphosphatase METABASIS THERAPEUTICS, INC. (US) 2008-03-20 US disclosed
US-20070225259-A1 Novel Thiazole Inhibitors of Fructose 1,6-Bishosphatase METABASIS THERAPEUTICS, INC. 2007-09-27 US disclosed
US-20070225259-A1 Novel Thiazole Inhibitors of Fructose 1,6-Bishosphatase METABASIS THERAPEUTICS, INC. 2007-09-27 US disclosed
US-20070225259-A1 Novel Thiazole Inhibitors of Fructose 1,6-Bishosphatase METABASIS THERAPEUTICS, INC. 2007-09-27 US disclosed
EP-1778250-A2 NOVEL THIAZOLE INHIBITORS OF FRUCTOSE 1,6-BISPHOSPHATASE Metabasis Therapeutics, Inc. (US) 2007-05-02 EP disclosed
WO-2006023515-A2 NOVEL THIAZOLE INHIBITORS OF FRUCTOSE 1,6-BISPHOSPHATASE METABASIS THERAPEUTICS, INC. (US) 2006-03-02 WO disclosed